DE69721134D1 - Verfahren zur Herstellung von 4-(2-(2-Pyridyl)Ethoxy)Benzaldehyd-Derivate - Google Patents

Verfahren zur Herstellung von 4-(2-(2-Pyridyl)Ethoxy)Benzaldehyd-Derivate

Info

Publication number
DE69721134D1
DE69721134D1 DE69721134T DE69721134T DE69721134D1 DE 69721134 D1 DE69721134 D1 DE 69721134D1 DE 69721134 T DE69721134 T DE 69721134T DE 69721134 T DE69721134 T DE 69721134T DE 69721134 D1 DE69721134 D1 DE 69721134D1
Authority
DE
Germany
Prior art keywords
chem
formula
compound represented
pyridyl
ethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69721134T
Other languages
English (en)
Other versions
DE69721134T2 (de
Inventor
Yuzuru Saito
Hideya Mizufune
Makoto Yamashita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DE69721134D1 publication Critical patent/DE69721134D1/de
Application granted granted Critical
Publication of DE69721134T2 publication Critical patent/DE69721134T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DE69721134T 1996-06-27 1997-06-26 Verfahren zur Herstellung von 4-(2-(2-Pyridyl)Ethoxy)Benzaldehyd-Derivate Expired - Lifetime DE69721134T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16786296 1996-06-27
JP16786296 1996-06-27

Publications (2)

Publication Number Publication Date
DE69721134D1 true DE69721134D1 (de) 2003-05-28
DE69721134T2 DE69721134T2 (de) 2004-03-04

Family

ID=15857471

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69721134T Expired - Lifetime DE69721134T2 (de) 1996-06-27 1997-06-26 Verfahren zur Herstellung von 4-(2-(2-Pyridyl)Ethoxy)Benzaldehyd-Derivate

Country Status (9)

Country Link
US (2) US5952509A (de)
EP (1) EP0816340B1 (de)
AT (1) ATE238282T1 (de)
CA (1) CA2208878C (de)
CY (1) CY2393B1 (de)
DE (1) DE69721134T2 (de)
DK (1) DK0816340T3 (de)
ES (1) ES2191811T3 (de)
PT (1) PT816340E (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
DZ2937A1 (fr) * 1998-11-12 2004-03-15 Smithkline Beecham Plc Compositions nouvelles de sensibilidants à l'insuline.
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
WO2002028857A1 (en) * 2000-10-05 2002-04-11 Dr. Reddy's Research Foundation Polymorphs of pioglitazone hydrochloride and their use as antidiabetics
FR2820742B1 (fr) * 2001-02-14 2005-03-11 Ppg Sipsy Procede de preparation de composes derives de thiazolidinedione, d'oxazolidinedione ou d'hydantoine
AU2002311057A1 (en) * 2001-04-26 2002-11-11 Leciva, A.S. Method for obtaining pioglitazone as an antidiabetic agent
AU2002337749A1 (en) * 2001-09-28 2003-04-07 Teva Pharmaceutical Industries Ltd. Pioglitazone hydrochloride
JP2005514390A (ja) * 2001-12-20 2005-05-19 テバ ファーマシューティカル インダストリーズ リミティド チアゾリジンジオン系糖尿病治療薬前駆体の水素化
US20050187258A1 (en) * 2001-12-20 2005-08-25 Ben-Zion Dolitzky Hydrogenation of precursors to thiazolidinedione antihyperglycemics
ATE321039T1 (de) * 2002-04-29 2006-04-15 Teva Pharma Verfahren zur herstellung von losartan und losartan-kaliumsalz
AU2002345524A1 (en) * 2002-06-19 2004-01-06 Eos Eczacibasi Ozgun Kimyasal Urunler Sanyi Ve Ticaret A.S. A process for the production of substituted phenyl ethers
US7232828B2 (en) * 2002-08-10 2007-06-19 Bethesda Pharmaceuticals, Inc. PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
WO2004024059A2 (en) * 2002-09-12 2004-03-25 Themis Laboratories Private Limited, Improved process for preparation of thiazolidinedione derivatives
PE20050335A1 (es) * 2003-08-07 2005-06-01 Sb Pharmco Inc Forma de dosificacion oral que comprende 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona y procedimiento para la preparacion
GB0318824D0 (en) * 2003-08-11 2003-09-10 Glaxo Group Ltd Novel composition
WO2005021542A2 (en) * 2003-08-28 2005-03-10 Ranbaxy Laboratories Limited Process for the preparation of pioglitazone
GB0325174D0 (en) * 2003-10-28 2003-12-03 Sandoz Ag Organic compounds
HUP0304096A2 (hu) * 2003-12-19 2005-08-29 Richter Gedeon Vegyészeti Gyár Rt. Eljárás pioglitazon hidrogénklorid előállítására és intermedierjei
US20080064877A2 (en) * 2004-05-12 2008-03-13 Medichem S.A. Process for the preparation of rosiglitazone
CN101184483B (zh) * 2005-06-08 2011-08-10 奥赖恩公司 含恩他卡朋的口服剂型
US20080182880A1 (en) * 2006-09-28 2008-07-31 Mailatur Sivaraman Mohan Pioglitazone composition
TW200914006A (en) * 2007-07-12 2009-04-01 Takeda Pharmaceutical Coated preparation
WO2012153312A1 (en) 2011-05-11 2012-11-15 Ranbaxy Laboratories Limited Process for the purification of pioglitazone
MX2016012687A (es) 2014-04-02 2017-04-27 Minoryx Therapeutics S L Derivados de 2,4-tiazolidindiona en el tratamiento de trastornos del sistema nervioso central.
MX2019006066A (es) 2016-12-01 2019-09-10 Minoryx Therapeutics S L 5-[[4-[2-[5-(1-hidroxietil)piridin-2-il]etoxi]fenil]metil]]-1,3-t iazolidin-2,4-diona para el tratamiento de enfermedad de higado graso no alcoholico.
DK3559010T3 (da) 2016-12-23 2022-08-15 Minoryx Therapeutics S L Fremgangsmåde til fremstilling af 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedion og salte deraf

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
DE69202715T2 (de) * 1991-03-25 1995-11-23 Takeda Chemical Industries Ltd Verfahren zur Herstellung von Ethern.
KR100249988B1 (ko) * 1991-04-11 2000-04-01 로렌스 티. 마이젠헬더 티아졸리딘디온 유도체, 그의 제조방법 및 용도

Also Published As

Publication number Publication date
EP0816340A1 (de) 1998-01-07
ES2191811T3 (es) 2003-09-16
EP0816340B1 (de) 2003-04-23
US5952509A (en) 1999-09-14
DK0816340T3 (da) 2003-07-14
DE69721134T2 (de) 2004-03-04
US6100403A (en) 2000-08-08
CA2208878C (en) 2002-08-20
ATE238282T1 (de) 2003-05-15
PT816340E (pt) 2003-08-29
CA2208878A1 (en) 1997-12-27
CY2393B1 (en) 2004-09-10

Similar Documents

Publication Publication Date Title
DE69721134D1 (de) Verfahren zur Herstellung von 4-(2-(2-Pyridyl)Ethoxy)Benzaldehyd-Derivate
BG105457A (en) Method for the preparation of citalopram
FI943164A0 (fi) 2-(1-(1,3-tiatsolin-2-yyli)atsetidin-3-yyli)tiokarbapeneemijohdannaisia
EA200300100A1 (ru) Способ получения производных 4-тиоалкилбромбензола
ATE151411T1 (de) Verfahren zur herstellung von methoxyminoacetamidverbindungen
DK0801054T3 (da) Fremgangsmåde til fremstilling af 2-(2-hydroxymethylphenyl)acetamidderivater og mellemprodukter til fremstilling deraf
ATE233249T1 (de) Verfahren zur herstellung von hiv protease inhibitoren
ATE496907T1 (de) Verfahren zur herstellung von cilostazol
DE69915413D1 (de) Verfahren zur Herstellung von 4-phenyl-1,2,3,6-tetrahydropyridin-derivaten und die dafür verwendeten Zwischenprodukte
TW341559B (en) Process for racemization of optically active 1-phenylethylamine derivative
WO1992015561A3 (en) Process for preparing trans-piperidine-2,5-dicarboxylates
IL108829A0 (en) Enzymatic resolution of alkyl 2-piperidinecarboxylates and use of the compounds obtained as synthesis intermediates
IE790771L (en) 1,2-disubstituted pyrrolidine and piperidine compounds.
PT945430E (pt) N-fenilacetoacetamidas e processo para a sua producao
ATE231858T1 (de) Verfahren zur herstellung von 3-substituierten 4- phenyl-piperidin derivaten
ATE189453T1 (de) Verfahren zur herstellung von 2-cyanobiphenyl- verbindungen
CA2345717A1 (en) Method for preparing trion-bis(oxime ether) derivatives andrion-mono and trion-bis(oxime ether) derivatives obtained therewith
ATA83990A (de) Verfahren zur herstellung von n-succinimidylcarbonaten
ATE207908T1 (de) Verfahren zur herstellung von 2-alkoxy-6- (trifluormethyl)-pyrimidin-4-ol
DE60222536D1 (de) Verfahren zur herstellung von 1-chlor-4-arylbutan
EP1074546A4 (de) 5-iod-4-phenylethylaminopyrimidin-derivate, zwischenverbindungen davon, verfahren zu ihrer herstellung und pestizide für landwirtschaft und gartenbau
HU901377D0 (en) Process for preparation of carbamates
HUP9902554A3 (en) Subsituted 3-aryl-3-carboxyalkyl glutaramides, method for preparing same, and use thereof for preparing 3-aryl-3-hydroxyalkylpiperidines
DE69422495D1 (de) Chinolondisulfide als zwischenverbindungen
ATE260264T1 (de) Verfahren zur herstellung von oxazol-derivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: TAKEDA PHARMACEUTICAL CO. LTD., OSAKA, JP